VIYASH SCIENTIFIC LIMITED (VIYASH) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical…

VIYASHUpdated 7 Sept 2026, 21:16

Viyash Scientific Limited

Market Cap

₹11,618Cr.

Current Price

₹264

High / Low

₹298/178

Stock P/E

136

Book Value₹73.0
Dividend Yield0.00%
ROCE5.57%
ROE3.43%
Face Value₹2.00

About

Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days9468455270946584872297124146
Inventory Days126943156498101154228129117172171
Days Payable13212335211320320819719399126146182
Cash Conversion Cycle8839417221-11-41411225388150136
Working Capital Days-20211554133312-6658722-585135
ROCE %24%3%0%35%1%3%5%2%-1%1%7%6%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 7 September 2026 at 21:16


Designed & Shipped by Harshit Bansal